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Abstract
Background: Malaria is still a public health problem in Malaysia especially in the interior parts of Peninsular
Malaysia and the states of Sabah and Sarawak (East Malaysia). This is the first study on the genetic diversity and
genotype multiplicity of Plasmodium falciparum in Malaysia.
Methods: Seventy-five P. falciparum isolates were genotyped by using nested-PCR of MSP-1 (block 2) and MSP-2
(block 3).
Results: MSP-1 and MSP-2 allelic families were identified in 65 blood samples. RO33 was the predominant MSP-1
allelic family identified in 80.0% (52/65) of the samples while K1 family had the least frequency. Of the MSP-2 allelic
families, 3D7 showed higher frequency (76.0%) compared to FC27 (20.0%). The multiplicity of P. falciparum
infection (MOI) was 1.37 and 1.20 for MSP-1 and MSP-2, respectively. A total of seven alleles were detected; of
which three MSP-1 allelic families (RO33, MAD20 and K1) were monomorphic in terms of size while MSP-2 alleles
were polymorphic (two 3D7 and two FC27). Heterozygosity (HE) was 0.57 and 0.55 for MSP-1 and MSP-2,
respectively.
Conclusions: The study showed that the MOI of P. falciparum is low, reflected the low intensity of malaria
transmission in Pahang, Malaysia; RO33 and 3D7 were the most predominant circulating allelic families. The
findings showed that P. falciparum has low allelic diversity with a high frequency of alleles. As a result, antimalarial
drug efficacy trials based on MSP genotyping should be carefully interpreted.
Background
Malaria has been a global health problem threatening
more than 40% of the world’s population, and about 300-
500 million cases of malaria infection are reported every
year with approximately one million deaths, mostly
among children and pregnant women [1]. Among the
malarial parasites, Plasmodium falciparum, causes the
most severe malarial attacks, is responsible for the high
morbidity and mortality, frequent antimalarial drug resis-
tance and aborted vaccines trials [2,3].
Genetic diversity determines the intensity of malaria
transmission, thus providing baseline data for any
antimalarial drug efficacy trial and the possibility of imple-
menting control strategies based on vaccines. Merozoite
surface proteins 1 and 2 (MSP-1 and MSP-2) are widely
used to study the allelic diversity and frequency of P. falci-
parum which are most commonly correlated with the
level of transmission in the area under study. The two loci
have also been introduced as a discriminatory tool to dis-
tinguish new from recrudescent infections [4,5].
Despite the tremendous reduction in malaria annual
cases achieved by The Malaria Control Programme (from
55,000 in 1990 to 7010 cases by 2009), malaria continues
to be a public health problem in Malaysia, especially in
rural and remote areas with P. falciparum, the most viru-
lent species, accounting for more than one third of the
reported malaria cases (Annual Reports, Ministry of
Health, Malaysia). Information about the genetic diversity
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of P. falciparum is lacking in Malaysia. This information
is necessary for implementing PCR-based antimalarial
drug efficacy trials to examine the current drug policy.
Genotyping P. falciparum in the antimalarial drug effi-
cacy trials prevents unnecessary change of drug policy
due to misclassification of re-infection in the follow-up
investigation as recrudescence. The discriminatory power
of the genotyping method depends on the allelic diversity
and frequency of P. falciparum in the study area. Thus,
the present study was carried out to investigate the
genetic diversity of P. falciparum isolated from Pahang,
Malaysia using merozoite surface protein-1 (MSP-1) and
merozoite surface protein-2 (MSP-2).
Methods
Sampling and malaria microscopy
A total of 822 blood samples were collected from differ-
ent districts of Pahang, Malaysia (Figure 1); 728 samples
by a survey and 64 by archived positive falciparum
malaria slides. In the survey, a finger prick blood sample
was taken from each subject for thick and thin blood film
and 2-3 drops were collected on 3 MM Whatman® filter
paper (Whatman International Ltd., Maidstone, England).
Blood films were stained with diluted Giemsa stain and
then examined microscopically for the presence of
malaria parasites; 200 fields under 1000× magnification
were examined from the thick film before the slide was
considered negative.
For positive slides, parasite species and stages were
reported and parasitaemia (parasite density) was deter-
mined by counting only the asexual stages against 300
white blood cells (WBC) and then multiplied by 25;
assuming the average of total WBC count of individuals
equal to 7500 cells per μl of blood [6]. The level of para-
sitaemia was graded as low (< 1000 parasites/μl of blood),
moderate (1000 - 9999 parasites/μl of blood) and severe
(≥ 10,000 parasites/μl of blood). Archived malaria posi-
tive slides were also re-examined; parasite species and
parasitaemia were recorded. All positive cases of single
and mixed falciparum infections were considered for the
molecular technique processing.
Molecular identification and genotyping
Genomic DNA was extracted from blood spots collected
on filter papers and from archived Giemsa blood smears.
Briefly, a disc of the filter paper was punched out from
the blood spot using a pre-flamed paper puncher and
placed in 1.5 ml centrifuge tubes using clean, flamed for-
ceps. Regarding archived slides, the slides were first
cleaned with chloroform to remove oil. Then, 50 ml of
TE buffer was transferred onto the smear and at least
half of the smear was completely wiped off the slide
using Whatman 1 filter paper and transferred into 1.5 ml
microcentrifuge tubes. Genomic DNA was extracted
using Qiagen blood and tissue kit (QIAGEN, DNeasy®
Blood & Tissue Kit, Cat. no. 69506, Germany) according
to the manufacurer’s instruction. DNA was eluted using
50 uL AE (10 mM Tris-Cl; 0.5 mM EDTA; pH 9.0) elu-
tion buffer (QIAGEN, DNeasy® Blood & Tissue Kit, Cat.
no. 69506, Germany) and kept at -20°C until used for
PCR. Plasmodium spp were identified by 18s rRNA-
based nested PCR using genus- and species - specific pri-
mers as mentioned previously [7].
P. falciparum were further analyzed by amplification of
the two highly polymorphic regions of MSP-1 (Block 2)
and MSP-2 (Block 3) using nested-PCR as mentioned
previously [8], with slight modifications for the cycling
conditions of the secondary PCR. Briefly, oligonucleotide
primers sets (Table 1), previously designed by Snounou
et al. [8], were used for detecting the different families
(K1, MAD20 and RO33 in MSP-1; FC27 and 3D7 in
MSP-2). In the primary PCR, a 50 μl PCR mixture was
used containing 5 μl of DNA extract, 1X of MgCl2 free
buffer, 1 mM of MgCl2, 125 μM of dNTPs, 250 mM of
each primer and 1.25 of Taq polymerase enzyme. All
reagents were from iNtRON (iNtRON Biotechnology,
Inc. Seoul, Korea). Cycling conditions for the primary
PCR were as follows; starting with three single steps of
denaturation at 94°C for 5 minutes, annealing at 58°C for
2 minutes and extension at 72°C for 2 minutes. This is
followed by 25 cycles of denaturation at 94°C for 1 min-
ute, annealing at 58°C for 2 minutes and extension at
72°C for 2 minutes, then a single annealing step at 58°C
for 2 minutes and final extension at 72°C for 5 minutes.
Three μl of primary PCR product were used as a DNA
template in the secondary PCR which had similar con-
centrations to the primary PCR. The cycling conditions
for the secondary PCR were as follows: starting with a
single step of denaturation at 95°C for 10 minutes fol-
lowed by 40 cycles of denaturation at 94°C for 30 sec-
onds, annealing at 58°C for 30 seconds and extension at
72°C for 1 minute, and a final extension at 72°C for 10
minutes. PCR reaction mixtures were incubated in a
thermal cycler (MyCycler-BioRad, Hercules, USA).
Detection of Alleles
The secondary PCR products were separated by electro-
phoresis on 7% polyacrylamide gel in 1X TBE (Tris-
borate EDTA) buffer stained with ethidium bromide.
Bands were visualized by the gel document system (Infi-
nity 3026, Vilber Lourmat, Marnela Valled, France) and
the sizes of the fragments were estimated by comparison
to the 100 bp DNA ladder (iNtRON Biotechnology, Inc.
Seoul, Korea). Fragments representing the different
alleles were selected and purified using a PCR purifica-
tion kit (iNtRON Biotechnology, MEGAquick-spin PCR
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& Agarose Gel DNA Extraction System, Cat. no. 17281,
Seoul, Korea). Purified PCR products for a limited num-
ber of isolates representing different alleles of MSP-1 and
MSP-2 were sequenced in both directions with the
primers of the secondary PCR using the ABI PRISM®
BigDyeTM terminator v3.0 Ready Reaction Cycle
Sequencing Kit according to the manufacurer’s instruc-
tion (Applied Biosystems, USA) in 3130 × l Genetic
Figure 1 A geographic map showing Peninsular Malaysia and Pahang’s districts.
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Analyzer (Applied Biosystems, USA). The sequences
were used to correct the estimated molecular weight and
to confirm the nature of the amplified product.
Multiplicity of infection and heterozygosity
The multiplicity of infection (MOI) or number of geno-
types per infection was calculated by dividing the total
number of fragments detected in MSP-1 or MSP-2 by
the number of samples positive for the same marker.
Heterozygosity which represents the probability of being
infected by two parasites with different alleles at a given
locus and ranging between 0 and 1 was calculated by
using the following formula: HE = [n/(n-1)] [(1-∑pi
2 )],
where n is the number of isolates sampled and pi is the
allele frequency at a given locus [5,9]. Isolates with
more than one genotype were considered as polyclonal
infection while the presence of a single allele was con-
sidered as monoclonal infection.
Statistical analysis
Data was analyzed using the SPSS for windows software
version 13. For descriptive analysis, proportion was used
to present the distribution of different allelic families
while the mean was used to present the MOI. Indepen-
dent t-test was used to compare the mean MOI accord-
ing to gender, time of the year of infection and
parasitaemia. A P value of ≤ 0.05 was considered indica-
tive of a statistically significant difference.
Ethical consideration
The protocol of this study (Reference Number: 788.73)
has been approved by the Medical Ethics Committee of
the University of Malaya Medical Centre, Kuala Lumpur,
Malaysia. The study was also registered with the
National Medical Research Registry, Malaysia (Research
ID: 5681). After a clear explanation of the objectives of
the study, the subjects concerned agreed to participate
in the study and verbal consents were obtained.
Results
P. falciparum parasites were detected in a total of 75
samples. This includes 64 archived positive slides, and
eleven blood samples out of 728 collected in the survey.
Of the total positive samples, 66% were from males and
34% were from females with a mean age of 27.8 years
and standard deviation of 4.1 years. Moreover, 64.2% of
the positive samples collected were from Malay, 23.9%
from aborigines, 6.5% from Indians and 2.7% from Chi-
nese. In addition, two cases were detected from foreign
workers who were residing in Malaysia for the past
three years. The asexual P. falciparum parasitaemia
from the collected samples ranged from 50 to 17,100
parasites/μl of blood with a geometric mean of 4,065
parasites/μl. Low parasitaemic individuals (parasite
count < 1000 parasites/μl of blood) represented 41.3%,
while moderate-to-high parasitaemia (parasite count ≥
1000 parasites/μl of blood) were 58.7%.
Multiplicity of infection and genetic diversity
All samples positive for P. falciparum were genotyped
using MSP-1 (Block-2) and MSP-2 (Block-3) by nested
PCR. Of these, 65 (87%) were found positive for MSP-1
and MSP-2 (40 with MSP-1only and 25 with both). Mul-
tiplicity of infection (MOI) was found to be 1.37 and
1.20 for MSP-1 and MSP-2, respectively (Table 2). Mean
MOI was compared according to parasitaemia (low and
Table 1 Sequences of the primers used to amplify the MSP-1 and MSP-2 genes of P. falciparum isolates from Pahang,
Malaysia
Amplification/Gene Primer Primer sequence
Primary PCR
MSP-1 M1-OF 5- -CTAGAAGCTTTAGAAGATGCAGTATTG-3-
M1-OR 5- -CTTAAATAGTATTCTAATTCAAGTGGATCA-3-
MSP-2 M2-OF 5- -ATGAAGGTAATTAAAACATTGTCTATTATA-3-
M2-OR 5- -CTTTGTTACCATCGGTACATTCTT-3-
Secondary PCR
MSP-1 M1-KF 5- -AAATGAAGAAGAAATTACTACAAAAGGTGC-3-
M1-KR 5- -GCTTGCATCAGCTGGAGGGCTTGCACCAGA-3-
M1-MF 5- -AAATGAAGGAACAAGTGGAACAGCTGTTAC-3-
M1-MR 5- -ATCTGAAGGATTTGTACGTCTTGAATTACC-3-
M1-RF 5- -TAAAGGATGGAGCAAATACTCAAGTTGTTG-3-
M1-RR 5- -CATCTGAAGGATTTGCAGCACCTGGAGATC-3-
MSP-2 M2-FCF 5- -AATACTAAGAGTGTAGGTGCARATGCTCCA-3-
M2-FCR 5- -TTTTATTTGGTGCATTGCCAGAACTTGAAC-3-
M2-ICF 5- -AGAAGTATGGCAGAAAGTAAkCCTYCTACT-3-
M2-ICR 5- -GATTGTAATTCGGGGGATTCAGTTTGTTCG-3-
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moderate-to-high), year of infection (2007/2008 and
2009/2010) and sex of patients. The mean MOI was
found to be higher in female patients, those diagnosed
in year 2009/2010, and in individuals with moderate-to-
high parasitaemia than male patients, those diagnosed in
year 2007/2008, and in those with low parasitaemia.
However, the differences in MOI between these groups
were not statistically significant (P > 0.05).
In MSP-1, RO33, MAD20 and K1 allelic families were
identified with an overall frequency of 89. RO33 allelic
family was predominant as it was identified in 80.0%
(52/65) of the samples. The distribution of the identified
MSP-1 allelic families is illustrated in Figure 2. One
third (33.8%) of the blood samples positive for MSP-1
were identified as polyclonal infections while two-thirds
(66.2%) were monoclonal infections. Among the polyclo-
nal infections, RO33/MAD20 and RO33/K1 constituted
18.5% (12/65) and 10.8% (7/65), respectively. Trimorphic
infections of MSP-1, ie. those having three allelic families,
were also reported in 3.1% of the cases. With respect to
MSP-2, 3D7 and FC27 allele types were detected among
the isolates (Figure 3). The frequency of samples with only
3D7 allelic family [76.0% (19/25)] was found to be higher
than the samples with only FC27 family [20.0% (5/25)].
However, MSP-2 with both allelic types was identified
only in one sample (4.0%). On the other hand, monoclonal
Table 2 Multiplicity of infection, heterozygosity and type of infection for MSP-1 and MSP-2 genes of P. falciparum
isolates from Pahang, Malaysia
Gene MOI
Mean (± SEM)
Heterozygosity Monoclonal infection
n (%)
Polyclonal infection
n (%)
MSP-1 1.37 (± 0.1) 0.57 43 (66.2) 22 (33.8)
MSP-2 1.20 (± 0.09) 0.55 20 (80.0) 5 (20.0)
n: number of cases. SEM: standard error of mean
Figure 2 Distribution of different allelic families of MSP-1 (n = 65).
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infection was reported in 80.0% (20/25) of cases positive
for MSP-2 alleles while 20% were polyclonal.
Allelic frequency and heterozygosity
The total number of detected alleles was seven. MSP-1
had three alleles; RO33 (150 bp), MAD20 (180 - 200 bp)
and K1 (200 bp). Within MSP-2 block, 3D7 family had
two different alleles; 3D7 (330 - 350 bp) and 3D7 (500 -
550 bp). Similarly, two different alleles were detected for
FC27 family; FC27 (300 - 330 bp) and FC27 (350 - 380
bp). The frequencies of these alleles based on PCR pro-
ducts size (base pairs, bp) and their combinations are
shown in Figures 2 and 3. Expected heterozygosity was
almost the same for MSP-1 locus (HE = 0.57) and MSP-2
locus (HE = 0.55).
Discussion
The present study is the first to provide information
about the genetic diversity of P. falciparum in Malaysia.
Our findings showed a low multiplicity of infection
(MOI) for both MSP-1 and MSP-2 reflecting the low
intensity of malaria transmission in Peninsular Malaysia.
This is in agreement with previous observations of an
increased MOI with increasing endemicity [10,11].
The present study showed that the frequency of the
MSP-1 allelic families was higher than MSP-2. The
predominant families in the MSP-1 and MSP-2 were
RO33 and 3D7, respectively. These findings are in
agreement with previous studies in Brazil and Gabon
which demonstrated the predominance of the RO33
allelic family [12,13]. By contrast, previous studies in
Thailand and Myanmar showed that MAD20 was the
predominant allelic family while RO33 family showed
either a very low frequency or not detected at all [8,14].
A topographic-based variation in the distribution of
MSP-1 allelic families within the same area was
described by a recent study from Indonesia which aimed
at comparing the distribution of MSP-1 allelic families
in coastal and mountainous areas in West Sumatera.
This study reported that K1 and MAD20 were the most
predominant allelic families in the coastal and mountai-
nous areas, respectively [15].
The association between the distribution of allelic
families and the severity of malaria has been investigated,
and the studies have yielded a variety of results. RO33
allelic family was frequently reported in asymptomatic
malaria cases and K1 family in severe cases [13,16]. This
is supported by a community-based study in Papua New
Guinea which reported an association between reduced
risk of clinical malaria and infection with parasites of
MSP-1 type RO33 or MSP-2 type 3D7 [17]. Moreover, a
study from Senegal showed that MSP-2 was found more
Figure 3 Distribution of different allelic families of MSP-2 (n = 25). * 3D7 (300-350 bp)/FC27 (350-380 bp).
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prevalent among patients with severe malaria than MSP-
1 [18]. On the other hand, previous studies revealed an
association between the dominance of K1 allelic family
and the existence of asymptomatic malaria infection
[19,20]. In this present study, we could not examine such
association as the majority of samples were archived
stained slides with unclear information on the severity of
malaria infections. However, among the eleven positive
blood samples collected by the survey, only one severe
malaria case was reported. A previous community-based
study which has been carried out in Pahang, Malaysia
indicated that most of the malaria patients diagnosed
during mass screening surveys conducted by malaria con-
trol units, were apparently healthy [21].
The present study found that about two-thirds of the
MSP-1 positive cases harbored a single allele (monoclo-
nal infection), and the polyclonal infection was reported
in 33.8%. On the other hand, 80.0% of the MSP-2 posi-
tive cases had monoclonal infection. These findings sug-
gested a low complexity of P. falciparum population.
Polyclonal type infections were found in the mesoen-
demic areas up to 50% as against 100% in holoendemic
areas [20,22,23]. Moreover, a previous study from
Congo showed a significant association between the
complexity of infection and polyclonal infections with
the asymptomatic malaria [24]. Another study aimed at
comparing the genetic diversity (based on MSP-1) of
malaria parasite in different countries of different ende-
micity levels showed that the presence of polyclonal
infection was more common in areas with high endemi-
city [25].
The present study reported few numbers of alleles
(seven alleles for both MSP-1 and MSP-2) circulating in
the study area with RO33 (150 bp) and 3D7 (500 - 550
bp) being highly frequent. We found that MSP-2 allelic
families 3D7 and FC27 exhibit size polymorphism while
MSP-1 allelic families K1, MAD20 and RO33 showed
monomorphic pattern. Previous studies reported that
MSP-2 gene is highly polymorphic compared to MSP-1
and among the MSP-1 alleles, RO33 found to be mono-
morphic compared to the polymorphic families K1 and
MAD20 [8,26]. Moreover, a previous study from a low
endemic country identified only one MAD20 allele of
MSP-1 while RO33 or K1 alleles were not found in any
sample [27]. It is reported that genomic DNA extracted
from archived stained blood slides showed a relatively
poor performance at low level parasitaemia and this
may explain the low detection of MSP-2 [28]. However,
we should indicate that all blood samples collected by
the survey were found to be positive for both MSP-1
and MSP-2.
The low allelic diversity together with the high fre-
quency of the circulating alleles increase the chance of
the re-infection with the same allele, decreasing the
discriminatory power of MSP-1 and MSP-2 to differenti-
ate between recrudescence and re-infection in Peninsu-
lar Malaysia. Thus, the genotyping of P. falciparum
based on MSP-1 and MSP-2 in antimalarial drug efficacy
trials, in Peninsular Malaysia, may lead to misclassifica-
tion of re-infection as recrudescence (treatment failure)
and cause unnecessary change of malaria drug policy.
However, the possibility of re-infection during the fol-
low-up may be low in an area with low intensity of
transmission. In the same vein, heterozygosity was 0.55-
0.57 suggesting that the parasite population in Pahang,
Malaysia exhibits intermediate heterozygosity, which is
consistent with the heterozygosity range (0.51-0.65)
reported in Southeast Asia/Pacific region [29]. In areas
with declining endemicity, it is reported that the num-
ber and diversity of alleles (heterozygosity) decrease
with decreasing P. falciparum transmission [29,30].
The correlation between the genetic variation of P. fal-
ciparum and malaria endemicity has been described
[10,11]. Our findings showed no significant difference in
the mean MOI according to sex of patients, level of
parasitaemia, and years of infection. This is in agree-
ment with previous reports in other countries [31,32].
In contrast, previous studies from Senegal, Mozambique
and Iran showed a significantly high MOI in patients
with moderate-to-high parasitaemia [33,34]. In the pre-
sent study, most of the positive samples were from adult
patients aged 22-40 years, and this limited range of age
constraint examining the difference in MOI according
to age. However, previous studies showed a pattern of
greater MOI in older individuals than younger indivi-
duals reflecting more previous exposure to infection
[35,36]. Conflicting findings, indicated decreased MOI
with age, were also reported [32,37].
Conclusions
This study provides information on the genetic diversity
of P. falciparum in Malaysia based of MSP-1 and MSP-
2. Malaria due to P. falciparum in Pahang state of
Malaysia was found mostly to be monoclonal infection
with generally low parasite diversity, together with high
predominance of RO33 allelic family of MSP-1 and 3D7
family of MSP-2. The low allelic diversity with the high
frequency of alleles may limit the use of MSP-based
genotyping in antimalarial drug efficacy trials in Penin-
sular Malaysia.
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